Search
Close this search box.
    • Small Molecules
    • Biologics
    • Other Drug Modalities
    • SynVent Integrated Drug Discovery
      • SynVent Integrated Drug Discovery

        SynVent is Syngene’s platform for fully integrated therapeutic discovery and development across large and small molecules. 

    • Industries
    • Emerging Biopharma
      • Emerging Biopharma

        Emerging biopharma work at the forefront of science, often venturing into disease areas where little or no real-world data exists to work with or regulatory frameworks to work within.

    • Dedicated Centers
      • Dedicated Centers

        Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support personnel, and a tailormade ring-fenced and fire-walled infrastructure as per client specifications to support their  R&D  goals

    • Center for Advanced Protein Studies (CAPS)
      • Center for Advanced Protein Studies (CAPS)

        Centre for Advanced Protein Studies [CAPS] is a state-of-the-art advanced national facility located in the Syngene campus, Bangalore.

  • Careers
Search
Close this search box.

Certifications

NABL Certificate of Accreditation (ISO 15189 :2012) for Medical Laboratories – Requirements for Quality and Competence (Medical Testing) for Syngene's Central Laboratory, Bengaluru, 02/2022 to 02/2024

Good Manufacturing Certificate for Syngene's Chemical Development Center (S14),Bengaluru, 01/2023 to 01/2024

Good Manufacturing Certificate for Syngene's API Manufacturing facility (MSEZ),Mangaluru, 10/2020 to 10/2025

ISO 13485: 2016 Certificate of Registration for Medical Device Quality Management Systems, for Syngene's Formulation unit (S15), Bengaluru, 09/2021 to 09/2024

ISO 9001: 2015 Certificate for Management Systems, Bengaluru, 01/2023 to 08/2025

Certificate of Accreditation by College of American Pathologists (CAP) for Syngene’s Central Laboratory, Bengaluru, 05/2024

Department of scientific and industrial research (DSIR) Certificate of Registration for Syngene’s in house R&D units, Bengaluru and Hyderabad, 03/2022 to 03/2025

NABL Certificate of Accreditation (ISO 15189:2012) for Medical Laboratories – Requirements for Quality and Competence, 02/2022 to 02/2024, Bengaluru

Certificate of GLP Compliance by national GLP compliance monitoring authority (NGCMA), department of science and technology (DST), Government of India (https://dst.gov.in/ngcma) in compliance with OECD principles of GLP, Bengaluru, 10/2022 to 10/2025

Department of Scientific and Industrial Research (DSIR) recognition for R&D units Syngene’s Block S20 Bengaluru /Hyderabad Unit from 7/21 to 3/22

Drug Manufacturing license for Syngene's Chemical Development Center ( S14 ) 02/17 to 02/22, Bengaluru

Drug Manufacturing license for Syngene's Formulation Center (S18FC/FDC) 02/17 to 02/22, Bengaluru

NABL accreditation certificate (ISO/IEC 17025:2017) for testing of medical devices for safety assessment, 12/20 to 12/22, Bengaluru

AAALAC accredition certificate for care and use of Lab animals, 07/18 to 03/21, Bengaluru

GMP manufacturing certificate for Syngene's Formulation Center (S18FC/FDC) 02/17 to 02/22, Bengaluru

Good Laboratory Practices (GLP) certified by NGCMA, Department of Science and Technology (DST), Government of India (https://dst.gov.in/ngcma) in compliance with OECD principles of GLP, 10/20 to 10/22, Bengaluru

Join Syngene
Be at the cutting-edge of scientific innovation

Your browser does not support this function.

To download, Please share your details

This Website uses Cookies

We use cookies to improve your experience on our site and show you information relevant to your requirements. To find out more, read our Privacy Policy and Cookies Policy. and

To view or email, Please share your details view

To download, Please share your details